Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Capsules vs
ARA-290 received FDA Orphan Drug Designation for this indication TRPV1-mediated pain models ARA-290 demonstrated specific inhibition of TRPV1 channel activity, relieving capsaicin-induced mechanical hypersensitivity in pre-clinical nociceptor models Complex Regional Pain Syndrome (CRPS) investigational studies have examined ARA-290 in CRPS models due to its dual anti-inflammatory and nociceptor-targeting mechanism Chronic neuropathic pain multiple studies confirm ARA-290 reduces neuroinflammation in the spinal cord by suppressing TNF-, IL-1, and other pro-inflammatory cytokines that maintain chronic pain states Neuroprotection and CNS Research: Cerebral ischaemia/stroke models Wang et al
Mild injection-site discomfort can happen after some injections
The BAC chart is different for men and women because of the Widmark r factor (0.66 female vs 0.73 male) and lower average total body water in biological females
The nine-state outbreak tied to iceberg lettuce accounts for 1,947 confirmed cases
Elevates oxygen-consumption rates in Seahorse and high-resolution respirometry protocols, enabling precise measurement of electron-transport-chain efficiency
US$ 27.80
US$ 24.73
US$ 22.15
US$ 25.18
US$ 28.40
US$ 23.94
US$ 29.59
US$ 23.66
US$ 27.30
US$ 29.18
US$ 28.39
US$ 21.01
US$ 25.36
